Status:
COMPLETED
Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.
Lead Sponsor:
Hospital Clinica Nova
Collaborating Sponsors:
Universidad de Monterrey
Politecnico di Milano
Conditions:
Vaccine Adverse Reaction
COVID-19
Eligibility:
All Genders
Brief Summary
Background: Scarce information exists in relation to the comparison of seroconversion and adverse events following immunization (AEFI) with different SARS-COV2 vaccines. Our aim was to correlate the m...
Detailed Description
The aim of this study is to compare the seroconversion after the first and second dose (if applicable) between BNT162b2 mRNA, mRNA-1273, ChAdOx1-S, Ad26.COV2, Ad5-nCoV, Gam-COVID-Vac, and Coronavac th...
Eligibility Criteria
Inclusion
- Participants of both genders at relevant vaccination places who consented to participate, planned to conclude the immunization regimen of any vaccine and agree to be followed-up for the duration of the study
Exclusion
- Previously given any SARS-CoV-2 vaccine prior to study entry
Key Trial Info
Start Date :
February 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2022
Estimated Enrollment :
1870 Patients enrolled
Trial Details
Trial ID
NCT05228912
Start Date
February 26 2021
End Date
October 30 2022
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinica Nova de Monterrey
San Nicolás de los Garza, Mexico, 66450